Rational pharmacotherapy of hypertension in the elderly: analysis of the choice and dosage of drugs.
OBJECTIVE
To determine in older people with uncomplicated hypertension: (a) the pattern of prescribing of antihypertensives; (b) the extent of physicians' adherence to recommendations on dosage for antihypertensive combinations; (c) whether prescribing practice conforms with recommended therapeutic guidelines; and (d) the frequency of prescribing of other drugs which have the potential to alter the efficacy of antihypertensive agents.


METHODS
A survey of prescribing in older patients with uncomplicated hypertension in primary care setting of Bahrain was conducted.


RESULTS
Of the 432 (56.5%) patients on monotherapy, 192 (44.4%) were treated with beta-blockers, 87 (20.1%) with calcium channel blockers (CCBs), 53 (12.3%) with alpha-methyldopa, 47 (10.9%) with diuretics, 46 (10.6%) with angiotensin converting enzyme (ACE) inhibitors, and 7 (1.6%) with hydralazine. Of the 1146 patients on mono- or combination therapies, 434 (56.8%) were treated with beta-blockers, 244 (31.9%) with diuretics, 211 (27.6%) with CCBs, 139 (18.2%) with ACE inhibitors, 103 (13.5%) with alpha-methyldopa 8 (1.0%) with brinerdine and 7 (0.9%) with hydralazine. In the 332 (43.5%) patients on combination therapy, 15 different two- and three-antihypertensive drug combinations were prescribed: a diuretic with a beta-blocker (37.2%) and a beta-blocker with either a CCB (20.9%) or an ACE inhibitor (12.4%) were the most popular two-drug regimens. The most commonly prescribed triple drug regimens were a diuretic and a beta-blocker plus either a CCB (26.1%) or an ACE inhibitor (17.4%) and diuretic plus an ACE inhibitor and a CCB (15.2%). Daily dosage of beta-blockers, ACE inhibitors and alpha-methyldopa were somewhat high in a considerable proportion of patients on both mono- and combined therapies. A substantial proportion (9.7%) of patients on monotherapy were treated with immediate release nifedipine.


CONCLUSIONS
The pharmacotherapy of hypertension in elderly patients was found in some instances not to conform to recommended guidelines. For certain classes of antihypertensive agent such as beta-blockers, ACE inhibitors and alpha-methyldopa, neither the principles of geriatric pharmacology nor of antihypertensive combination therapy, and in particular, the need to reduce daily dosage, were followed. The use of immediate release nifedipine in the elderly is irrational, and instead, the use of long-acting dihydropyridine CCBs should be considered. The results of long-term randomized clinical trials published during the last decade have had a minimal impact on clinical practice of primary care physicians in Bahrain.
Jassim Al Khaja
K A
KA
Department of Pharmacology and Therapeutics, College of Medicine and Medical Sciences, Arabian Gulf University, Bahrain. khlidj@agu.edu.bh
Sequeira
R P
RP
Mathur
V S
VS
D000368:Aged; D000369:Aged, 80 and over; D000959:Antihypertensive Agents / Q000008:administration & dosage* / Q000627:therapeutic use; D004347:Drug Interactions; D011307:Drug Prescriptions; D005260:Female; D019538:Health Care Surveys; D006299:Health Services for the Aged; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D008297:Male; D010818:Practice Patterns, Physicians'
D000959:Antihypertensive Agents